NHS England invites 75–80-year-olds for their first respiratory syncytial virus (RSV) vaccines – why should not those in their 80s be included too?

Article

Merchant, H. A. 2025. NHS England invites 75–80-year-olds for their first respiratory syncytial virus (RSV) vaccines – why should not those in their 80s be included too? Journal of Pharmaceutical Policy and Practice. 18 (1), p. Art. 2477761. https://doi.org/10.1080/20523211.2025.2477761
AuthorsMerchant, H. A.
Abstract

This editorial has no abstract.

JournalJournal of Pharmaceutical Policy and Practice
Journal citation18 (1), p. Art. 2477761
ISSN2052-3211
Year2025
PublisherTaylor & Francis
Publisher's version
License
File Access Level
Anyone
Digital Object Identifier (DOI)https://doi.org/10.1080/20523211.2025.2477761
Publication dates
Online19 Mar 2025
Publication process dates
Deposited30 May 2025
Copyright holder© 2025 The Author
Permalink -

https://repository.uel.ac.uk/item/8z9vy

Log in to edit

Download files

Publisher's version
NHS England invites 75 80-year-olds for their first respiratory syncytial virus RSV vaccines why should not those in their 80s be included too .pdf
License: CC BY 4.0
File access level: Anyone

  • 35
    total views
  • 7
    total downloads
  • 7
    views this month
  • 1
    downloads this month

Export as

Related outputs

Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry
Arman, B. Y., Clarke, R., Bharucha, T., Fernandez, L. G., Walsby-Tickle, J., Deats, M., Mosca, S., Lin, Q., Banerjee, S., Chunekar, S. R., Patil, K. D., Gairola, S., Dunachie, S., Ali, H., Stokes, R., Kuwana, R., Maes, A., Charrier, J-P., Probert, F., Caillet, C., Matousek, P., McCullagh, J., Newton, P. N., Zitzmann, N. and Gangadharan, B. 2025. Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry. npj Vaccines. 10 (Art. 19). https://doi.org/10.1038/s41541-024-01051-3
A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study
Michael Nwanosike, E., Merchant, H. A., Sunter, W., Ayub Ansari, M., Conway, B. R. and Shahzad Hasan S. 2024. A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study. Journal of Nephrology. 37, pp. 1227-1240. https://doi.org/10.1007/s40620-024-01930-x
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains
Bharucha, T., Gangadharan, B., Clarke, R., Gomez Fernandez, L., Yohan Arman, B., Walsby-Tickle, J., Deats, M., Mosca, S., Lin, Q., Stokes, R., Dunachie, S., Merchant, H. A., Dubot-Pérès, A., Caillet, C., McCullagh, J., Matousek, P., Zitzmann, N. and Newton, P. N. 2024. Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains. Vaccine. 42 (7), pp. 1506-1511. https://doi.org/10.1016/j.vaccine.2024.01.019
Intragastric balloons for obesity: critical review of device design, efficacy, tolerability, and unmet clinical needs
Ameen, S. and Merchant, H. A. 2023. Intragastric balloons for obesity: critical review of device design, efficacy, tolerability, and unmet clinical needs. Expert Review of Medical Devices. 21 (1-2), pp. 37-54. https://doi.org/10.1080/17434440.2023.2289691